Category Specific RSS

Categories: Satire

Meghan Markle gracefully withdraws from Nobel Prize consideration

Following the successful release of her children’s book The Bench’, author Meghan Markle has withdrawn herself from Nobel Prize consideration to give her fellow literary masterminds a level playing field not impacted by her public profile.

With the Duchess of Sussex now adding ‘author’ to her decorated career as an actor, producer and now Non-Royal, sources close to the family confirmed that Markle did not want her literary career to overshadow her on-screen successes. 

“Departing the Royal Family was all about taking a step back from the public spotlight so she didn’t feel the need to accept the many literary awards that are coming her way,” said one of her aides. 

“It just wouldn’t be fair for Pablo Neruda or Ernest Hemmingway to have their work overshadowed by ‘The Bench’ if Meghan was to join them as winners of the Nobel Prize in Literature.” 

‘The Bench’ sold 3,212 copies in its first week of sales.

Elias Pivep

Failed stand-up comic who now gets his kicks from Simpsons business memes.

Recent Posts

Atomo Locks in US$410K Pascal Order as FebriDx Demand Accelerates in the US

Atomo Diagnostics (ASX:AT1) has secured a significant new order for its patented Pascal cassette, with…

1 week ago

June 2025 quarter CPI no roadblock to August RBA rate cut

The June 2025 quarter CPI data released today were cheered by mortgage holders and share…

2 weeks ago

Vection Secures $7.3M Defence Extension as AI Demand Strengthens

AI Gains Ground in Defence Sector As governments increase investment in defence technology, AI-powered tools…

2 weeks ago

Calix Secures $44.9m ARENA Grant to Build Green Iron Plant with ZESTY Technology

Calix Limited (ASX:CXL) has taken a significant leap forward in developing Australia’s low-emissions steel value…

3 weeks ago

Harris Technology boosts retail margins in FY25 through growth of refurbished tech

Online tech retailer Harris Technology (ASX: HT8) has delivered a strong lift in gross product…

3 weeks ago

Lumos Diagnostics Secures US$317M Deal to Distribute FebriDx® in U.S.

In a significant move set to reshape rapid diagnostics in the U.S., ASX-listed Lumos Diagnostics…

4 weeks ago